Retapamulin is a topical antibiotic and the first pleuromutilin antibiotic approved for human use. It is developed for use as a pharmaceutical raw material in manufacturing ointments.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 224452-66-8
Nitrofurazone
pharmaceutical raw material
Calcium orotate
pharmaceutical raw material
Benfotiamine
pharmaceutical raw material
Hydroxocobalamin acetate
pharmaceutical raw material
Vardenafil hydrochloride
pharmaceutical raw material
[(1S,2R,3S,4S,6R,7R,8R,14R)-4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl] 2-[[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl]sulfanyl]acetate
STZYTFJPGGDRJD-FJJJPKKESA-N
C[C@@H]1CC[C@@]23CCC(=O)[C@H]2[C@@]1([C@@H](C[C@@]([C@H]([C@@H]3C)O)(C)C=C)OC(=O)CSC4C[C@H]5CC[C@@H](C4)N5C)C